Tariffs & Duties #tariffs#generic drugs
Trump's Generic Drug Tariffs Explained: What It Means for Indian Pharma Before the 200% Storm
US President Donald Trump unveiled a phased tariff plan for imported generic medicines: duty-free for two years from August 1, then 100% for one year, followed by 200%. For Indian drugmakers, the plan offers temporary relief but signals a long-term shift. India's pharma exports to the US account for 34% of total pharma exports, worth $30.47 billion in 2024-25. Leading companies with US manufacturing operations may have greater flexibility.
Jul 22, 2026 1 source